Form 4 Filing for Immunovant, Inc.

On December 16, 2024, Christopher Van Tuyl was granted 109,956 restricted stock units (RSUs). Of these, 6,872 RSUs vested on September 16, 2026. The reported sale of 2,846 shares of Common Stock by Mr. Van Tuyl on September 23, 2026, was to cover tax withholding obligations amounting to $36.36 per share (weighted average). This sale was mandated by the issuer's policy for tax withholding and does not represent a discretionary transaction. The weighted average sale price ranged from $36.35 to $36.66 per share. Following this transaction, Mr. Van Tuyl owns 176,545 shares directly.